Knockdown of TRB3 induces apoptosis in human lung adenocarcinoma cells through regulation of Notch 1 expression.

The upregulation of tribbles homolog 3 (TRB3), a pseudokinase in mammals, has been observed in several types of malignant cancer, including thyroid, ovarian, liver and colorectal cancer. However, the pathological role and the regulatory mechanism of TRB3 in cancer remain unknown. In the current study, we demonstrated that the expression of TRB3 was upregulated in non-small cell lung cancer (NSCLC), correlating with tumor metastasis, disease recurrence and poor survival in patients. Knocking down TRB3 in aggressive lung cancer cell lines was demonstrated to significantly inhibit their malignant behaviors, including in vitro invasion and cell proliferation, as well as in vivo metastasis and tumor growth. The correlation between TRB3 and Notch 1 expression revealed that Notch 1 was downregulated by the knockdown of TRB3 in the lung adenocarcinoma cell lines. These results have provided insights into the correlation between TRB3 expression and lung cancer progression, and thus may have potential for the prognosis and therapy of lung cancer.

[1]  Jeffrey L. Wrana,et al.  High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer , 2013, Proceedings of the National Academy of Sciences.

[2]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[3]  Ziyan Wang,et al.  TRB3 interacts with SMAD3 promoting tumor cell migration and invasion , 2011, Journal of Cell Science.

[4]  J. Bussink,et al.  Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response , 2011, Breast Cancer Research.

[5]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[6]  Yibin Kang,et al.  Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.

[7]  Stephen A. Ramsey,et al.  ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells , 2010, Journal of Cell Science.

[8]  K. Mimori,et al.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis , 2009, British Journal of Cancer.

[9]  P. Knaus,et al.  Recent advances in BMP receptor signaling. , 2009, Cytokine & growth factor reviews.

[10]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[11]  Pier Paolo Di Fiore,et al.  The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer , 2009, Nature Cell Biology.

[12]  C. Hsieh,et al.  A functional Notch–survivin gene signature in basal breast cancer , 2008, Breast Cancer Research.

[13]  D. Altieri,et al.  Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. , 2008, Cancer research.

[14]  A. Ben-Ze'ev,et al.  Epithelial-mesenchymal transition and the invasive potential of tumors. , 2008, Trends in molecular medicine.

[15]  Shinya Watanabe,et al.  NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. , 2008, Cancer research.

[16]  Pier Paolo Di Fiore,et al.  NUMB controls p53 tumour suppressor activity , 2008, Nature.

[17]  S. Narod,et al.  Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.

[18]  R. Clarke,et al.  Mammary Stem Cells and Breast Cancer—Role of Notch Signalling , 2007, Stem Cell Reviews.

[19]  Jun Wu,et al.  TRB3 interacts with CtIP and is overexpressed in certain cancers. , 2007, Biochimica et biophysica acta.

[20]  N. Webster,et al.  Effect of TRB3 on Insulin and Nutrient-stimulated Hepatic p70 S6 Kinase Activity* , 2006, Journal of Biological Chemistry.

[21]  G. Barton,et al.  Emerging roles of pseudokinases. , 2006, Trends in cell biology.

[22]  A. Klippel,et al.  TRB3 is a PI 3-kinase dependent indicator for nutrient starvation. , 2006, Cellular signalling.

[23]  G. Lockwood,et al.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.

[24]  H. Hayashi,et al.  TRB3, a novel ER stress‐inducible gene, is induced via ATF4–CHOP pathway and is involved in cell death , 2005, The EMBO journal.

[25]  Patrick Maisonneuve,et al.  Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.

[26]  H. Moses,et al.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.

[27]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3 , 2004, Nature Medicine.

[28]  Marc Montminy,et al.  TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver , 2003, Science.

[29]  S. Scully,et al.  SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia , 2003, Oncogene.

[30]  W. Hahn,et al.  Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells , 2002, Nature Medicine.

[31]  M. Leptin,et al.  Tribbles, a cell-cycle brake that coordinates proliferation and morphogenesis during Drosophila gastrulation , 2000, Current Biology.

[32]  E. Wieschaus,et al.  A Genetic Link between Morphogenesis and Cell Division during Formation of the Ventral Furrow in Drosophila , 2000, Cell.

[33]  Tasuku Honjo The shortest path from the surface to the nucleus: RBP‐Jκ/Su(H) transcription factor , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  Erna Raja Cross-regulation between TGFβ/BMP Signalling and the metabolic LKB1 pathway , 2012 .

[35]  H. Berman,et al.  Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer. , 2011, Cancer research.

[36]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.